Tadalafil
Product Images NDC 50436-0370

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50436-0370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl504360370)

This is a description of a medicine called Tadalafil. It comes in the form of tablets, with each containing 5mg of Tadalafil USP. The tablets should be kept in light containers, at a controlled room temperature of 23 degrees Celsius. The package insert contains instructions on dosage information. The medicine is RX only, and the lot numbers are listed as 00X, LTY B 9000, and O ooy B 00. The text also includes several warnings, including to keep the medicine out of reach of children, and to only take the prescribed dose.*

FDA Label Image

Figure (Tadalafil Figure1)

The text appears to be a table showing the difference in blood pressure (measured in mmHg) between Tadalafil and Placebo for both standing and supine positions. However, without a proper table format and context, it is difficult to provide a more specific description.*

FDA Label Image

Figure (Tadalafil Figure2)

The text appears to be a mix of numerical values, symbols, and scattered letters/words. It is not possible to generate a useful description.*

FDA Label Image

Figure (Tadalafil Figure3)

FDA Label Image

Figure (Tadalafil Figure4)

This is a chart showing plasma tadalafil concentrations in ug/L over time for different doses and durations of administration. The doses evaluated are a single 20-mg tadalafil dose, a single 5-mg tadalafil dose, and once-daily 5-mg tadalafil following 5 consecutive days of administration. The x-axis shows time in hours up to 120 hours, and the y-axis shows plasma tadalafil concentration in ug/L.*

FDA Label Image

Figure 5 (Tadalafil Figure5)

The text is describing the change in IPSS total score as a result of either taking tadalafil or a placebo during a treatment that lasted for 12 weeks. The graph displays a significant difference between the two groups with a p-value of less than 0.01.*

FDA Label Image

Figure 6 (Tadalafil Figure6)

FDA Label Image

Figure 7 (Tadalafil Figure7)

Not available.*

FDA Label Image

Figure 8 (Tadalafil Figure8)

FDA Label Image

Chemical Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.